However, in conditions such as obesity and diabetes, the regulation and effectiveness of ANP may be impaired, contributing to an increased risk of heart failure and atherosclerosis [6]. The gene discussed is NPPA; the disease is obesity due to melanocortin 4 receptor deficiency.